Spectral Diagnostics Inc. (DIAGF)
-OTC Markets 0.20 May 10, 3:19PM EDT|Pre-Market
:
NaN
| Prev Close: | 0.20 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.18 - 0.30 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 12,368 |
|---|
| Market Cap: | 23.08M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.08 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Spectral announces first quarter 2013 resultsCNW Group(Wed, May 15)
- Spectral Appoints Vice President of Sales and MarketingCNW Group(Tue, May 7)
- Spectral Diagnostics adopts new By-Laws which contain advance notice provisionsCNW Group(Tue, Apr 16)
- SPECTRAL DIAGNOSTICS INC FinancialsEDGAR Online Financials(Wed, Apr 10)
- Spectral Diagnostics Closes $5.6 Million OfferingCNW Group(Tue, Apr 2)
- Spectral announces fourth quarter and fiscal 2012 resultsCNW Group(Wed, Mar 27)
- Spectral Diagnostics increases offering to $5.6 millionCNW Group(Mon, Mar 18)
- Toray Industries makes $5 million strategic investment in Spectral DiagnosticsCNW Group(Thu, Mar 7)
- Spectral announces results of first interim analysis by Data Safety and Monitoring BoardCNW Group(Mon, Feb 4)
- SPECTRAL DIAGNOSTICS INC FinancialsEDGAR Online Financials(Fri, Aug 24)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 8.39 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Spectral Diagnostics Inc. engages in the development and commercialization of theranostic treatment for severe sepsis and septic shock in North America.
View More 
0.12%